From: Impact of the faecal immunochemical test on colorectal cancer survival
GROUP 1 N = 279 N (%) | GROUP 2 N = 1248 N (%) | p | |
---|---|---|---|
AGE (years) | |||
≤ 49 | 13 (4.7) | 52 (4.2) | |
50–69 | 74 (26.5) | 423 (33.9) | 0.06 |
≥ 70 | 192 (68.8) | 773 (61.9) | |
SEX | |||
(% men) | 63% | 59% | 0.17 |
SITE* | |||
Rectum | 67 (24.1) | 300 (24.0) | |
Distal colon | 115 (41.2) | 564 (45.2) | 0.31 |
Proximal colon | 94 (33.7) | 364 (29.2) | |
Unknown | 3(1.0) | 20(1.6) | |
HISTOLOGY | |||
Adenocarcinoma | 267 (95.7) | 1184 (94.9) | |
Mucinous adenocarcinoma | 7 (2.5) | 41 (3.3) | 0.8 |
Others** | 5 (1.8) | 23 (1.8) | |
STAGE | |||
Stage I | 51 (18.3) | 170 (13.6) | |
Stage II | 92 (33.0) | 398 (31.9) | |
Stage III | 64 (22.9) | 308 (24.7) | 0.04(***) |
Stage IV | 72 (25.8) | 370 (29.7) | |
Unknown | – | 2(0.1) |